Unravelling lipid heterogeneity: Advances in single-cell lipidomics in cellular metabolism and disease

Recent advancements in single-cell analysis have revolutionized our understanding of cellular heterogeneity, particularly in lipid metabolism. Single-cell lipidomics, enabled by ultra-sensitive mass spectrometry techniques such as Orbitrap and Fourier-transform ion cyclotron resonance (FT-ICR), prov...

Full description

Saved in:
Bibliographic Details
Main Authors: Sutanu Sarkar, Rajgourab Ghosh
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:BBA Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667160325000328
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent advancements in single-cell analysis have revolutionized our understanding of cellular heterogeneity, particularly in lipid metabolism. Single-cell lipidomics, enabled by ultra-sensitive mass spectrometry techniques such as Orbitrap and Fourier-transform ion cyclotron resonance (FT-ICR), provides unprecedented insights into lipid-mediated cellular functions. Unlike bulk analyses, single-cell approaches capture real-time metabolic changes, highlighting lipid species' roles in cell differentiation, signal transduction, and disease progression. Mass spectrometry imaging (MSI), including MALDI-MSI and SIMS, further delineates lipid distributions within tissues, revealing spatial heterogeneity critical to cellular function. Emerging evidence suggests that lipid alterations significantly impact developmental mechanisms, stem cell niches, and disease pathogenesis, challenging conventional bulk-level assumptions. However, a key challenge remains in deciphering how lipid networks coordinate cellular differentiation and transcriptional regulation. Future research must integrate lipidomic, proteomic, and genomic data to unravel lipid-mediated signaling and epigenetic modifications. Understanding these dynamics will advance regenerative medicine and therapeutic interventions, enabling precise targeting of lipid-driven pathways in disease contexts.
ISSN:2667-1603